Johnson & Johnson Halts Sale Of Power Morcellators Following FDA Warning
This article was originally published in The Gray Sheet
Executive Summary
The firm’s Ethicon unit is suspending its line of laparoscopic power morcellation systems for hysterectomy or myomectomy now that FDA has officially discouraged the procedure.